Ibogaine vs. Ketamine: Which Psychedelic Therapy Is Right for You?

Ketamine clinics have proliferated across the United States. Ibogaine treatment centers cluster across the border in Mexico. Both are being discussed as breakthroughs in mental health and addiction treatment — but they work very differently, cost very differently, and are suited to very different patients.

How They Work

Ketamine is a dissociative anesthetic that has been used in medicine for decades. At sub-anesthetic doses, it produces a brief dissociative experience — typically 45–60 minutes — that appears to promote neuroplasticity and rapidly reduce symptoms of depression. The mechanism is primarily through NMDA receptor antagonism and the downstream release of BDNF, a protein that supports neuron growth and connectivity.

Ibogaine is a far more complex compound. It acts on more than a dozen receptor systems simultaneously — opioid receptors, serotonin transporters, NMDA receptors, sigma receptors, and others. The experience it produces is dramatically longer (18–36 hours) and more intense. Its effects on addiction, particularly opioid addiction, appear to be unique and are not replicated by ketamine.

What Each Treats Best

Ketamine has the strongest evidence base for treatment-resistant depression. It is also used for anxiety, OCD, and chronic pain. It is FDA-approved (as esketamine/Spravato) for treatment-resistant depression, making it accessible within the US healthcare system.

Ibogaine has the strongest evidence for opioid use disorder. The Stanford study and decades of clinical observation suggest it can interrupt opioid addiction in a single session in a way that no other treatment replicates. It also shows strong results for PTSD, trauma, and depression — but the evidence base, while compelling, is less mature than ketamine's.

Cost and Accessibility

Ketamine infusions in the US typically cost $400–$800 per session, with an initial series of six sessions recommended. Some insurance plans now cover esketamine. Total initial cost: $2,400–$4,800.

Ibogaine treatment in Mexico costs $6,000–$15,000 for a complete program including medical screening, the session itself, and integration support. It is not covered by insurance. Travel and accommodation add to the cost.

Duration of Effect

Ketamine's antidepressant effects typically last 2–4 weeks per infusion, requiring ongoing maintenance sessions. It is, for many patients, a long-term treatment protocol.

Ibogaine's effects appear to be more durable. Many patients report sustained improvements in addiction, mood, and cognition for months or years after a single treatment. Some require a second session; many do not.

The Bottom Line

If you are primarily dealing with treatment-resistant depression and want a legal, US-accessible option, ketamine is the more practical starting point. If you are dealing with opioid addiction, or if you have tried ketamine without sufficient results, ibogaine in Mexico deserves serious consideration — with appropriate medical screening and a reputable clinic.